查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1835064

不孕症检测市场（按类型、产品、技术和最终用户）—2025-2032 年全球预测

Fertility Testing Market by Type, Product, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，不孕症检测市场规模将成长至 7.7028 亿美元，复合年增长率为 9.13%。

主要市场统计数据
基准年2024年 3.829亿美元
预计2025年 4.176亿美元
预测年份：2032年 7.7028亿美元
复合年增长率（%） 9.13%

策略入门，重点介绍临床需求、消费者主导的诊断、技术融合以及影响不孕症检测的商业化优先事项

不孕症检测领域是一个复杂的生态系统，临床需求、消费者赋能和快速的技术进步交织在一起，需要清晰的思路和策略远见。临床医生和诊断实验室正在探索新的患者诊疗路径，而个人也越来越多地获得复杂的居家诊断服务。同时，产品创新者正在将实验室级分析与以用户为中心的数位体验相结合，以重塑生育健康的评估、追踪和应对方式。

本执行摘要概述了关键趋势及其对整个价值链相关人员的实际影响。它强调了照护现场方法的不断发展、孕前保健中基因筛检服务的日益成熟，以及数位诊断在将生物讯号转化为可操作指导方面日益增长的影响力。它还揭示了监管变化、报销争议和付款人审查如何影响临床应用和商业策略。

本概述透过临床路径、技术赋能因素和最终用户期望来建立当前环境，为明智的决策奠定基础。领导者可以找到有助于确定投资优先顺序的背景讯息，识别营运漏洞，并发掘伙伴关係机会，从而在保持临床严谨性和品质保证的同时，加速接触高价值患者群体。

技术融合、患者主导的数位化应用以及不断发展的法律规范如何重新定义不孕症检测生态系统

不孕症检测领域正在经历变革时期，这得益于消费医疗技术与临床诊断技术的整合。数位化检测套组和可重复使用的监测解决方案增强了纵向追踪能力，而酵素结合免疫吸附检测法和数位成像等实验室检测法则继续为复杂的荷尔蒙和基因评估提供分析支撑。这种技术互补性正在催生混合护理模式，即诊所检测、参考实验室分析和家庭监测并存，从而提供更丰富的临床资讯。

同时，患者行为也在不断演变。人们寻求更早、更频繁、更个人化的生殖健康洞察，这推动了直接面向消费者和临床医生辅助的居家检测项目的成长。这种需求推动了对使用者体验、远端医疗整合和数据互通性的投资，以确保检测结果反映在护理路径中并支援共用决策。监管机构正在更新指南，以平衡可及性、分析效度和适当临床解读的需求，从而影响产品设计和商业化时间表。

最后，随着医疗服务提供者和供应商探索配套服务、订阅监控和结果主导定价，以协调相关人员之间的奖励机制，商业模式也在改变。这些动态预示着未来不孕症检测将更加连续、数位化，并融入更广泛的生殖健康进程。

评估累积关税变化将如何影响生育诊断供应链的弹性、筹资策略、临床可及性和产品设计

影响诊断组件和成品设备的关税波动可能会改变不孕症检测相关人员的供应链经济状况、筹资策略和上市时间动态。进口试剂、感测器和某些电子元件的关税上调可能会增加诊所平台和家用检测套组的单位成本，迫使製造商和经销商重新评估筹资策略和合约条款。为此，许多公司正在考虑组装组装、筛选合格的替代供应商，并重新设计产品物料材料清单，以减少关税敏感内容。

在营运方面，关税可能会延长前置作业时间，并扰乱就地检验服务和参考实验室的库存规划，因为清关和合规检查更加复杂。这种延误可能会增加关键试剂和耗材的安全库存，从而增加营运资金。从临床可及性的角度来看，成本压力可能会影响与付款人和医院系统的定价和报销谈判，也可能推迟采用更新、高成本的诊断方法，直到其价值提案得到明确论证。

从策略角度来看，关税正在加速供应商整合，并提升合约弹性的重要性。采购团队更重视总到岸成本分析、关税减免条款和多方采购安排，以维持服务水准。同时，采用模组化设计和软体主导差异化策略的公司或许能够更好地吸收离散成本衝击，同时又不损害临床报告品质和病患体验。

详细的細項分析揭示了测试类型、产品管道、检测技术和最终用户采用情况的需求驱动因素

细分揭示了测试形式、产品管道、检测技术和最终用户的不同需求驱动因素和营运考虑。基于类型的测试管道包括用于监测内分泌状态的荷尔蒙测试、用于确定受孕窗口的排卵测试、用于确认受孕的怀孕测试以及用于评估男性不孕参数的精子品质测试。这些针对特定产品类型的专业测试在分析复杂性和临床解读方面各不相同，从而导致产品和服务需求的多样化。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 人工智慧驱动的荷尔蒙分析平台在个人化生育能力评估的应用日益增多
  • 扩展与数位健康平台整合的综合家用不孕不育检测套组
  • 人们对男性不孕因素的认识不断提高，推动了对男性不孕症检测解决方案的需求激增
  • 将基因筛检和孕前带因者检测整合到标准不孕症治疗检测中
  • 微生物组分析测试的出现，有助于评估生殖健康和优化生育能力
  • 引入远距不孕症治疗咨询与家庭检体采集服务结合
  • 开发穿戴式生物感测器设备，用于在怀孕週期内持续监测激素
  • 基于区块链的资料安全解决方案确保直接面向消费者的生育测试的隐私
  • 加强生育诊所与数位治疗提供者之间的合作，提供全面的护理
  • 简化创新不孕症诊断技术核准流程的监管变化

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章不孕症检测市场（按类型）

  • 荷尔蒙测试
  • 排卵测试
  • 妊娠试验
  • 精子品质测试

第九章不孕症检测市场（按产品）

  • 基于临床的检测
    • 荷尔蒙面板测试
    • 在诊所进行排卵测试
    • 诊所的妊娠测试
  • 基因检测
    • 携带者筛检
    • 怀孕前基因检测
  • 家庭检测套组
    • 数位测试套件
    • 可重复使用的监视器套件
    • 试纸测试套件
  • 化验服务
    • 就地检验服务
    • 参考化验服务

第十章 不孕症检测市场（依技术）

  • 数位影像
  • 酵素结合免疫吸附试验
  • 侧流免疫检测

第 11 章不孕症检测市场（依最终用户）

  • 诊断实验室
  • 不孕不育诊所
  • 医院
  • 个人

第十二章不孕症检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章不孕症检测市场（按群体）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 不孕症检测市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • The Procter & Gamble Company
    • F. Hoffmann-La Roche AG
    • CooperSurgical, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • QIAGEN NV
    • Abbott Laboratories
Product Code: MRR-4348D129FB2F

The Fertility Testing Market is projected to grow by USD 770.28 million at a CAGR of 9.13% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 382.90 million
Estimated Year [2025] USD 417.60 million
Forecast Year [2032] USD 770.28 million
CAGR (%) 9.13%

A strategic primer illuminating clinical demand, consumer-driven diagnostics, technological convergence, and commercialization priorities shaping fertility testing

The fertility testing landscape sits at the intersection of clinical demand, consumer empowerment, and rapid technology advancement, creating a complex ecosystem that requires clarity and strategic foresight. Clinical practitioners and diagnostic laboratories are navigating new patient pathways while individuals are accessing increasingly sophisticated home diagnostics. Concurrently, product innovators are converging laboratory-grade analytics with user-centric digital experiences, reshaping how fertility health is assessed, tracked, and acted upon.

This executive summary synthesizes core trends and practical implications for stakeholders across the value chain. It emphasizes the evolving role of point-of-care modalities, the maturation of genetic screening services in preconception care, and the expanding influence of digital diagnostics that translate biological signals into actionable guidance. Moreover, the narrative highlights how regulatory shifts, reimbursement conversations, and payer scrutiny are influencing clinical adoption and commercial strategies.

By framing the current environment through clinical pathways, technology enablers, and end-user expectations, the overview provides a foundation for informed decision-making. Leaders will find context that supports prioritization of investments, identifies operational vulnerabilities, and surfaces partnership opportunities that accelerate access to high-value patient segments while maintaining clinical rigor and quality assurance.

How technological convergence, patient-driven digital adoption, and evolving regulatory frameworks are redefining the fertility testing ecosystem

The landscape of fertility testing is undergoing transformative shifts driven by convergence between consumer health technology and clinical diagnostics. Digital test kits and reusable monitor solutions are enhancing longitudinal tracking capabilities, while laboratory-based assays such as enzyme linked immunosorbent assays and digital imaging continue to provide the analytical backbone for complex hormone and genetic evaluations. This technological complementarity is enabling hybrid care models where in-clinic testing, reference laboratory analytics, and at-home monitoring coexist to deliver richer clinical narratives.

Simultaneously, patient behavior is evolving; individuals are seeking earlier, more frequent, and more personalized insights into reproductive health, prompting growth in both direct-to-consumer offerings and clinician-mediated home testing programs. This demand is reinforcing investments in user experience, telehealth integration, and data interoperability so that test results can feed care pathways and support shared decision-making. Regulatory bodies are responding with updated guidance that balances accessibility with the need for analytical validity and appropriate clinical interpretation, which in turn is shaping product design and commercialization timelines.

Finally, commercial models are shifting as providers and suppliers explore bundled services, subscription monitoring, and outcome-driven pricing to align incentives across stakeholders. These dynamics collectively point toward a future where fertility testing is more continuous, digitally enabled, and integrated into broader reproductive health journeys.

Assessment of how cumulative tariff shifts influence supply chain resilience, procurement strategy, clinical access, and product design across fertility diagnostics

Tariff changes affecting diagnostics components and finished devices can alter supply chain economics, procurement strategies, and time-to-market dynamics for fertility testing stakeholders. Cumulatively, increased duties on imported reagents, sensors, and certain electronic components have the potential to raise unit costs for both clinic-based platforms and home test kits, prompting manufacturers and distributors to reassess sourcing strategies and contract terms. In response, many companies consider nearshoring assembly, qualifying alternate suppliers, and redesigning product bills of materials to reduce tariff-sensitive content.

Operationally, tariffs can extend lead times as customs clearance and compliance checks become more complex, which may disrupt inventory planning for point-of-care testing services and reference labs. These delays incentivize higher safety stocks for critical reagents and consumables, thereby increasing working capital requirements. From a clinical access perspective, cost pressures could influence pricing and reimbursement negotiations with payers and hospital systems, and could also slow the adoption cadence for newer, higher-cost diagnostic modalities until value propositions are clearly demonstrated.

Strategically, tariffs accelerate supplier consolidation conversations and increase the importance of contractual agility. Procurement teams are placing greater emphasis on total landed cost analysis, tariff mitigation clauses, and multi-sourcing arrangements to maintain service levels. At the same time, companies with modular designs and software-driven differentiation may be better positioned to absorb discrete cost shocks without compromising the quality of clinical reporting or patient experience.

Deep segmentation analysis revealing distinct demand drivers across test types, product channels, assay technologies, and end-user adoption profiles

Segmentation reveals distinct demand drivers and operational considerations across testing formats, product channels, technologies, and end users. Based on type, testing pathways encompass hormone tests that monitor endocrine status, ovulation tests that pinpoint fertile windows, pregnancy tests that confirm conception, and sperm quality tests that evaluate male fertility parameters. These type-specific assays differ in analytical complexity and clinical interpretation, leading to divergent product and service requirements.

Based on product, the market spans clinic-based tests, genetic tests, home test kits, and lab services. Clinic-based tests include hormone panel assays, in-clinic ovulation diagnostics, and in-clinic pregnancy confirmation services that rely on trained personnel and integrated clinical workflows. Genetic tests cover carrier screening and preconception genetic assessments that demand high analytical accuracy and robust counseling frameworks. Home test kits range from digital test kits with app connectivity to reusable monitor kits and cost-effective strip-based options that prioritize ease of use. Lab services incorporate point-of-care testing services for near-patient diagnostics alongside reference lab services that support high-complexity assays and advanced analytics.

Based on technology, platforms are differentiated by digital imaging techniques, enzyme linked immunosorbent assay methodologies for quantitative biomarker detection, and lateral flow immunoassay approaches that enable rapid, qualitative results. Based on end user, the ecosystem serves diagnostic laboratories, fertility clinics, hospitals, and individual consumers, each with unique quality, regulatory, and data integration expectations. Recognizing these segmentation layers helps stakeholders prioritize product development, distribution models, and clinical engagement strategies tailored to the specific demands of each cohort.

Regional dynamics and market-entry imperatives that determine clinical adoption, reimbursement, and distribution strategies across major global territories

Regional dynamics shape clinical pathways, regulatory expectations, and commercial priorities across the fertility testing landscape. In the Americas, markets are characterized by a high degree of private-sector innovation, strong direct-to-consumer engagement, mature payer discussions, and an emphasis on integrated digital solutions that link home testing with telehealth and clinic follow-up. These factors create fertile ground for subscription-based monitoring services and partnerships between diagnostic developers and care networks.

Across Europe, the Middle East & Africa, regulatory harmonization, public healthcare procurement frameworks, and diverse access models influence how fertility tests are adopted. In many markets, reimbursement mechanisms and centralized procurement shape supplier selection, while countries with advanced genetics infrastructures are accelerating the integration of carrier and preconception screening into routine care. In contrast, regions with constrained laboratory capacity are prioritizing robust point-of-care solutions and simpler, high-value diagnostic tools that reduce referral burdens.

In the Asia-Pacific region, rapid digital adoption, sizable consumer markets, and expanding private healthcare sectors are driving growth in home testing and hybrid care models. Local manufacturing initiatives and regional supply-chain investments are also influencing product availability and cost structures. Collectively, these regional nuances highlight the need for market-entry strategies that balance regulatory compliance, distribution partnerships, and culturally appropriate patient engagement to maximize uptake and clinical impact.

Competitive differentiation through clinical validation, digital integration, strategic partnerships, and adaptive manufacturing approaches

Leading companies operating in fertility testing are differentiating along multiple dimensions: platform breadth, depth of clinical validation, digital integration, and channel partnerships. Some firms invest heavily in expanding laboratory capabilities and reference services to support complex genetic and hormone assays, while others focus on consumer-centric design to scale home test kits with seamless app-based interpretation. Across the competitive set, successful players balance rigorous analytical performance with clear clinical utility and user experience that reduces friction for both patients and providers.

Strategic collaborations between diagnostics developers, fertility clinics, and digital health platforms are becoming more common as companies seek to embed testing within longitudinal care pathways. Partnerships that enable bundled service offerings-combining initial screening, confirmatory laboratory testing, and clinician-led follow-up-are proving effective at driving adherence and generating richer outcome data. Additionally, M&A and licensing activity is reshaping capability stacks, with acquisitions frequently aimed at adding assay expertise, digital engagement tools, or regulatory footholds in target markets.

Companies prioritizing open data architectures and interoperability are positioning themselves to win in an environment where integrated care and outcome measurement matter. Finally, those with modular product roadmaps and flexible manufacturing strategies can react more nimbly to tariff pressures, supply chain disruptions, and changing reimbursement landscapes, thereby maintaining continuity of supply and preserving clinician and patient trust.

Practical imperatives for leaders to strengthen evidence, enable modular product design, secure supply resilience, and integrate diagnostics into care pathways

Industry leaders should prioritize a set of pragmatic actions that enhance resilience, accelerate adoption, and protect clinical integrity. First, invest in dual-pathway clinical evidence that demonstrates both analytical validity and real-world clinical utility across settings ranging from point of care to reference labs; such evidence supports payer conversations and clinician confidence. Next, design product portfolios with modular hardware and software components to enable rapid product reconfiguration and minimize exposure to tariff and component shortages.

Simultaneously, deepen partnerships with fertility clinics, diagnostic laboratories, and telehealth providers to create end-to-end patient journeys that reduce abandonment and improve diagnostic-to-treatment conversion. Align commercial models with outcomes by piloting bundled services and subscription monitoring to capture lifetime patient value and encourage adherence. Strengthen procurement and supplier management by implementing total landed cost analytics and multi-source strategies to mitigate single-supplier risk and customs-driven delays.

Finally, prioritize data governance, interoperability, and clinician-facing decision support so that test results translate into actionable care plans. By focusing on evidence generation, modular design, strategic partnerships, procurement sophistication, and data integration, industry leaders can convert market complexity into competitive advantage and sustained clinical impact.

Rigorous multi-method research approach combining primary stakeholder interviews, secondary clinical and regulatory synthesis, and transparent data triangulation

The research underpinning this executive summary is built on a multi-method approach that integrates primary qualitative interviews, secondary literature synthesis, and cross-validation with subject-matter experts. Primary inputs included structured interviews with clinicians, diagnostic laboratory directors, procurement leaders, and digital health executives to capture front-line perspectives on adoption barriers, workflow integration, and unmet clinical needs. Secondary analysis synthesized regulatory guidance, product technical specifications, and peer-reviewed literature to ensure analytical assertions were grounded in verifiable technical and clinical standards.

Data triangulation was employed to reconcile differing stakeholder viewpoints and identify robust themes. Where quantitative datasets were incorporated, care was taken to validate sources and ensure appropriate interpretation without projecting forward-looking estimates. The methodology emphasizes transparency of assumptions, clear documentation of data provenance, and a candid assessment of limitations, including potential regional heterogeneity and variability in clinical practice patterns. Ethical considerations and data privacy standards guided engagement protocols for interviews and the handling of any de-identified clinical datasets.

Finally, the research process prioritized actionable insight over descriptive reporting, using iterative synthesis to transform evidence into strategic recommendations that are relevant to commercial, clinical, and policy stakeholders operating in the fertility testing domain.

Synthesis of strategic priorities highlighting the need for evidence-based innovation, interoperable systems, and operational resilience to accelerate clinical adoption

The fertility testing domain is at an inflection point where technological maturation, changing patient expectations, and evolving commercial models converge to create new opportunities and responsibilities for stakeholders. Diagnostics developers and service providers must navigate an increasingly hybrid environment in which home-based monitoring complements laboratory-grade assays, and where data integration underpins clinical decision-making. As a result, the pathways by which tests are delivered, interpreted, and acted upon are changing, requiring coordinated responses across product development, clinical validation, and commercial channels.

Stakeholders who invest in rigorous evidence generation, prioritize interoperability, and structure partnerships with clinical care providers will be best placed to demonstrate value and secure long-term adoption. Equally important is the need for operational resilience in the face of supply chain and tariff pressures, which underscores the importance of procurement sophistication and flexible manufacturing strategies. Ultimately, the field will progress most effectively when innovations are paired with robust clinical governance and patient-centered design, ensuring that diagnostic advancements translate into improved reproductive health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing use of AI-driven hormonal profiling platforms for personalized fertility assessments
  • 5.2. Expansion of at-home comprehensive fertility test kits integrating digital health platforms
  • 5.3. Surging demand for male fertility testing solutions driven by rising awareness of male infertility factors
  • 5.4. Integration of genetic screening and preconception carrier tests in standard fertility workups
  • 5.5. Emergence of microbiome analysis tests to assess reproductive tract health and optimize fertility
  • 5.6. Adoption of telehealth fertility consultations linked with home-based sample collection services
  • 5.7. Development of wearable biosensor devices for continuous hormone monitoring during fertility cycles
  • 5.8. Blockchain-based data security solutions ensuring privacy in direct-to-consumer fertility testing
  • 5.9. Increased collaboration between fertility clinics and digital therapeutics providers for holistic care
  • 5.10. Regulatory shifts streamlining approval processes for innovative fertility diagnostic technologies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Testing Market, by Type

  • 8.1. Hormone Test
  • 8.2. Ovulation Test
  • 8.3. Pregnancy Test
  • 8.4. Sperm Quality Test

9. Fertility Testing Market, by Product

  • 9.1. Clinic Based Tests
    • 9.1.1. Hormone Panel Tests
    • 9.1.2. In-Clinic Ovulation Tests
    • 9.1.3. In-Clinic Pregnancy Tests
  • 9.2. Genetic Tests
    • 9.2.1. Carrier Screening
    • 9.2.2. Preconception Genetic Tests
  • 9.3. Home Test Kits
    • 9.3.1. Digital Test Kits
    • 9.3.2. Reusable Monitor Kits
    • 9.3.3. Strip Based Test Kits
  • 9.4. Lab Services
    • 9.4.1. Point Of Care Testing Services
    • 9.4.2. Reference Lab Services

10. Fertility Testing Market, by Technology

  • 10.1. Digital Imaging
  • 10.2. Enzyme Linked Immunosorbent Assay
  • 10.3. Lateral Flow Immunoassay

11. Fertility Testing Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Fertility Clinics
  • 11.3. Hospitals
  • 11.4. Individuals

12. Fertility Testing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fertility Testing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fertility Testing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. The Procter & Gamble Company
    • 15.3.2. F. Hoffmann-La Roche AG
    • 15.3.3. CooperSurgical, Inc.
    • 15.3.4. Siemens Healthineers AG
    • 15.3.5. Thermo Fisher Scientific Inc.
    • 15.3.6. Quest Diagnostics Incorporated
    • 15.3.7. Laboratory Corporation of America Holdings
    • 15.3.8. Merck KGaA
    • 15.3.9. QIAGEN N.V.
    • 15.3.10. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. FERTILITY TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. FERTILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FERTILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 331. ASEAN FER